Claus Juan Møller-San Pedro
Director/Board Member bij Terranol A/S
Profiel
Claus Juan Møller-San Pedro was the founder of I.
P.
Cons ApS (1994) and Azanta A (1994), where he held the titles of Chief Executive Officer and Managing Director, respectively.
He is currently a Director at Terranol A.
Dr. Møller-San Pedro's former positions include Director at EpiTherapeutics ApS, Medical Director at Synthélabo Scandinavia A, Director, Chief Executive & Commercial Officer at Y-mAbs Therapeutics, Inc., Executive VP, Chief Operating & Medical Officer at Oncotelic Therapeutics, Inc., Chief Operating Officer & Executive Vice President at Genmab A, and President at IPC Corp.
Ltd.
Dr. Møller-San Pedro holds a doctorate degree from the University of Copenhagen.
Actieve functies van Claus Juan Møller-San Pedro
| Bedrijven | Functie | Begin |
|---|---|---|
Terranol A/S
 Terranol A/S Miscellaneous Commercial ServicesCommercial Services Terranol A/S develops yeasts to be applied in second generation bioethanol production. Its second generation bioethanol is produced from agricultural wastes, such as wheat straw, sugar cane bagasse, corn stover, and wood chips. It has developed industrial yeasts that converts all sugars and also the sugar xylose in biomass into ethanol. The company's technology Terranol Strain V-1 ferments glucose and xylose into ethanol with high yield and low production of the byproduct xylitol. Terranol was founded by Thomas Hvid Andersen, Birgitte Rønnow, and Ole Sibbesen in October 2007 and is headquartered in Kongens Lyngby, Denmark. | Director/Board Member | 08-07-2009 |
Eerdere bekende functies van Claus Juan Møller-San Pedro
| Bedrijven | Functie | Einde |
|---|---|---|
| Y-MABS THERAPEUTICS, INC. | Chief Executive Officer | 22-04-2022 |
Azanta A/S
 Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. | Chief Executive Officer | 01-01-2015 |
| GENMAB A/S | Chief Operating Officer | 01-01-2008 |
I. P. Cons ApS
 I. P. Cons ApS Real Estate DevelopmentFinance I. P. Cons ApS engages in the trading and leasing activity with property and equipment. It also offers investment and financing activities. The company was founded by Claus Juan Møller-San Pedro on December 23, 1994 and is headquartered in Rungsted Kyst, Denmark. | Chief Executive Officer | - |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Director/Board Member | - |
Opleiding van Claus Juan Møller-San Pedro
| University of Copenhagen | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Health Technology |
| GENMAB A/S | Health Technology |
| IPC CORPORATION LTD | Consumer Services |
| Y-MABS THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
I. P. Cons ApS
I. P. Cons ApS Real Estate DevelopmentFinance I. P. Cons ApS engages in the trading and leasing activity with property and equipment. It also offers investment and financing activities. The company was founded by Claus Juan Møller-San Pedro on December 23, 1994 and is headquartered in Rungsted Kyst, Denmark. | Finance |
Terranol A/S
Terranol A/S Miscellaneous Commercial ServicesCommercial Services Terranol A/S develops yeasts to be applied in second generation bioethanol production. Its second generation bioethanol is produced from agricultural wastes, such as wheat straw, sugar cane bagasse, corn stover, and wood chips. It has developed industrial yeasts that converts all sugars and also the sugar xylose in biomass into ethanol. The company's technology Terranol Strain V-1 ferments glucose and xylose into ethanol with high yield and low production of the byproduct xylitol. Terranol was founded by Thomas Hvid Andersen, Birgitte Rønnow, and Ole Sibbesen in October 2007 and is headquartered in Kongens Lyngby, Denmark. | Commercial Services |
EpiTherapeutics ApS
EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Health Technology |
| Synthélabo Scandinavia A/S | |
Azanta A/S
Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. | Health Technology |
